Mirum Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 6.57 M | $271.69 M | 0.00% | 13.75% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 4.58 M | $189.48 M | 2.26% | 9.59% |
| BLACKROCK, INC. | 02/07/2025 | 3.43 M | $142.02 M | 1.97% | 7.19% |
| BVF INC/IL | 02/14/2025 | 2.80 M | $115.64 M | -9.08% | 5.85% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/14/2025 | 2.61 M | $107.80 M | -24.33% | 5.46% |
| VANGUARD GROUP INC | 02/11/2025 | 2.42 M | $100.26 M | -2.86% | 5.07% |
| CITADEL ADVISORS LLC | 02/14/2025 | 1.51 M | $62.49 M | 8.61% | 3.16% |
| NOVO HOLDINGS A/S | 02/14/2025 | 1.50 M | $62.03 M | 0.00% | 3.14% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 1.47 M | $60.85 M | -6.89% | 3.08% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 1.42 M | $58.83 M | 10.80% | 2.98% |
| STATE STREET CORP | 02/14/2025 | 1.38 M | $57.13 M | -22.97% | 2.89% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.24 M | $51.15 M | -3.88% | 2.59% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 943,344 | $39.02 M | 0.76% | 1.97% |
| CLEARBRIDGE INVESTMENTS, LLC | 02/12/2025 | 907,317 | $37.52 M | 2.05% | 1.90% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 860,096 | $35.56 M | -3.97% | 1.80% |
| LORD, ABBETT & CO. LLC | 02/14/2025 | 782,354 | $32.35 M | 5.53% | 1.64% |
| MORGAN STANLEY | 02/14/2025 | 758,380 | $31.36 M | 21.16% | 1.59% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 722,155 | $29.86 M | 46.66% | 1.51% |
| POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 675,000 | $27.91 M | 0.00% | 1.41% |
| AVIDITY PARTNERS MANAGEMENT LP | 02/14/2025 | 666,200 | $27.55 M | -8.88% | 1.39% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 590,662 | $24.42 M | -0.34% | 1.24% |
| BIOIMPACT CAPITAL LLC | 02/14/2025 | 589,579 | $24.38 M | 19.66% | 1.23% |
| BOONE CAPITAL MANAGEMENT LLC | 02/14/2025 | 581,843 | $24.06 M | 6.99% | 1.22% |
| LOOMIS SAYLES & CO L P | 02/12/2025 | 578,024 | $23.90 M | 15.76% | 1.21% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 555,636 | $22.98 M | -12.91% | 1.16% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 526,974 | $21.79 M | 15.68% | 1.10% |
| FIRST TURN MANAGEMENT, LLC | 02/14/2025 | 506,908 | $20.96 M | -21.73% | 1.06% |
| PROSIGHT MANAGEMENT, LP | 02/14/2025 | 451,127 | $18.65 M | -3.16% | 0.94% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 442,627 | $18.30 M | -5.06% | 0.93% |
| CANDRIAM S.C.A. | 02/07/2025 | 429,731 | $17.77 M | -15.49% | 0.90% |
| AXA S.A. | 02/14/2025 | 425,646 | $17.60 M | -0.10% | 0.89% |
| WOODLINE PARTNERS LP | 02/14/2025 | 404,404 | $16.72 M | 22.17% | 0.85% |
| NORTHERN TRUST CORP | 02/14/2025 | 399,544 | $16.52 M | 8.72% | 0.84% |
| JPMORGAN CHASE & CO | 02/12/2025 | 385,142 | $15.93 M | 1,287.35% | 0.81% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 332,639 | $13.75 M | 1.36% | 0.70% |
| INVESCO LTD. | 02/13/2025 | 299,279 | $12.38 M | 5.18% | 0.63% |
| PENN CAPITAL MANAGEMENT COMPANY, LLC | 02/14/2025 | 278,427 | $11.51 M | -9.97% | 0.58% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 261,644 | $10.82 M | 100.00% | 0.55% |
| 02/10/2025 | 260,000 | $10.72 M | 0.00% | 0.54% | |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 256,612 | $10.61 M | 100.00% | 0.54% |
| BARCLAYS PLC | 02/13/2025 | 251,964 | $10.42 M | 2.46% | 0.53% |
| RICE HALL JAMES & ASSOCIATES, LLC | 01/31/2025 | 238,999 | $9.88 M | -1.53% | 0.50% |
| NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 228,351 | $9.44 M | 0.00% | 0.48% |
| ENSIGN PEAK ADVISORS, INC | 02/14/2025 | 218,588 | $9.04 M | -0.82% | 0.46% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 194,076 | $8.02 M | 5.85% | 0.41% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 190,476 | $7.88 M | 0.00% | 0.40% |
| ARDSLEY ADVISORY PARTNERS LP | 02/14/2025 | 190,000 | $7.86 M | 0.00% | 0.40% |
| UBS GROUP AG | 02/14/2025 | 184,589 | $7.63 M | 48.40% | 0.39% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 176,960 | $7.32 M | 162.65% | 0.37% |
| MARSHALL WACE, LLP | 02/13/2025 | 175,913 | $7.27 M | 641.56% | 0.37% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Mirum Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 216 institutional investors and hedge funds held shares of Mirum Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Frazier Life Sciences Management, L.P.: 6.57 M
JANUS HENDERSON GROUP PLC: 4.58 M
BlackRock, Inc.: 3.43 M
BVF INC/IL: 2.8 M
EVENTIDE ASSET MANAGEMENT, LLC: 2.61 M
VANGUARD GROUP INC: 2.42 M
110.92% of Mirum Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 57.38 M shares in the last 24 months. This purchase volume represents approximately $2.19 B in transactions.